FDA Inspection
Huntsville Reproductive Medicine P.C.Huntsville Reproductive Medicine P.C. – FDA Inspection, Feb 22, 2013
Record Details
This FDA Inspection record concerns Huntsville Reproductive Medicine P.C., with an inspection on February 22, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- February 22, 2013
- Product Type
- Biologics
View Company Profile
ID · d6554a6a-4479-45a5-a38c-62fd16f6f8e7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 820792
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.160(d)Documentation/approval prior to implementation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Huntsville Reproductive Medicine P.C.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 26, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| July 12, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 5, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 2, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Huntsville Reproductive Medicine P.C.
- FDA Inspection 1187473 - 2022-10-26
- FDA Inspection 1058611 - 2018-07-12
- FDA Inspection 983625 - 2016-08-05
- FDA Inspection 729969 - 2011-06-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.